Vaccine News and Research

Latest Vaccine News and Research

NanoBio to present data from preclinical studies at 8th Annual International RSV Symposium

NanoBio Corporation announced today it will present data from three preclinical studies at the 8th Annual International Respiratory Syncytial Virus (RSV) Symposium taking place from Sept. 27-30 in Santa Fe, N.M.

25 Sep 2012

Simple survey can effectively identify women with ovarian cancer symptoms

A simple three-question paper-and-pencil survey, given to women in the doctor's office in less than two minutes, can effectively identify those who are experiencing symptoms that may indicate ovarian cancer, according to a study by researchers at Fred Hutchinson Cancer Research Center.

24 Sep 2012

Newly discovered Eilat virus harmless and potentially valuable

A mosquito sample collected three decades ago in Israel's Negev Desert has yielded an unexpected discovery: a previously unknown virus that's closely related to some of the world's most dangerous mosquito-borne pathogens but, curiously, incapable of infecting non-insect hosts.

24 Sep 2012

Transmitted HIV strains may have evolutionary advantage, suggest scientists

A new study has found that even though HIV diversifies widely within infected individuals over time, the virus strains that ultimately are passed on through heterosexual transmission often resemble the strain of virus that originally infected the transmitting partner.

24 Sep 2012

Cholera vaccine stockpiles could help save lives in future outbreaks

In a post in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, Helen Matzger, a program officer in new vaccine delivery at the foundation, writes about outbreaks of cholera in Haiti, Sierra Leone, Guinea, and other areas, and says creating stockpiles of a recently WHO-approved cholera vaccine could help save lives in the future.

21 Sep 2012

Biovest seeks EMA approval for BiovaxID to treat non-Hodgkin's lymphoma

Biovest International, Inc., a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc., today reported milestone achievements advancing BiovaxID, Biovest's personalized cancer vaccine for the treatment of non-Hodgkin's lymphoma, including a recently conducted regulatory meeting with the European Medicines Agency (EMA) and the appointment of a key contributor to the Human Genome Project to its Scientific Advisory Board.

21 Sep 2012

'Greater commitment' needed to fight NTDs

In a guest post on USAID's "IMPACT Blog," Rachel Cohen, regional executive director of DNDi North America, writes, "The United States government and its country partners should be commended for the tremendous achievements in the fight against neglected tropical diseases (NTDs) as part of the U.S. Agency for International Development (USAID) NTD Program" and the National Institutes of Health.

20 Sep 2012

BMJ examines emergence of China as 'major new player' in global vaccine production

"The Chinese drug industry is on the verge of getting the green light to manufacture the Japanese encephalitis vaccine for the developing world, an event that will signal the emergence of a major new player in global vaccines," BMJ reports.

20 Sep 2012

Bill Gates describes how 'catalytic philanthropy' can help bring vaccines, medicines to untouched markets

In an essay adapted for Forbes magazine from a speech given at the Forbes 400 Summit on Philanthropy in June, Bill Gates, co-chair of the Bill & Melinda Gates Foundation, discusses how "innovations for the poor suffer from ... market limitations" and his idea of "catalytic philanthropy." Gates writes, "The market is not going to place huge bets on research when there are no buyers for a breakthrough. This explains why we have no vaccine for malaria today, even though a million people die from it every year."

20 Sep 2012

Scientists identify unique molecular signature in iPSCs that show promise in regenerative medicine

Salk scientists have identified a unique molecular signature in induced pluripotent stem cells (iPSCs), "reprogrammed" cells that show great promise in regenerative medicine thanks to their ability to generate a range of body tissues.

20 Sep 2012

Study uncovers why some HIV-positive people take long time to progress to full-blown AIDS

One of the big mysteries of AIDS is why some HIV-positive people take more than a decade to progress to full-blown AIDS, if they progress at all.

20 Sep 2012

TECHLAB to utilize Dynex's Gold SmartKit packaging for ELISA product line

Dynex Technologies, Inc. announced today it has finalized a supply agreement with TECHLAB, Inc. (Blacksburg, VA), allowing TECHLAB to utilize Dynex's Gold SmartKit packaging for their ELISA product line.

20 Sep 2012

Complete story behind connection between XMRV virus and prostate cancer

A once-promising discovery linking prostate cancer to an obscure retrovirus derived from mice was the result of an inadvertent laboratory contamination, a forensic analysis of tissue samples and lab experiments - some dating back nearly a decade - has confirmed.

20 Sep 2012

Dengue Vaccine Initiative launches redesigned website, new blog

The Global Network for Neglected Tropical Diseases' "End the Neglect" blog reports that the Dengue Vaccine Initiative has launched a redesigned website, including a new blog that "will include regular posts about the disease, dengue in the news, the work of DVI and the development of a dengue vaccine."

19 Sep 2012

VOA News report examines PEPFAR's use of generic drugs, discusses search for HIV vaccine

In a recent edition of VOA News' "Science In The News," correspondents Bob Doughty and Shirley Griffith report on "the growing use of generic drugs in fighting HIV" and discuss "the search for an effective vaccine against HIV."

19 Sep 2012

Hereditary blood disorder found in South-East Asia, South-West Pacific could offer clues for malaria vaccine

"A team of international scientists has found that a type of hereditary disorder in some communities in South-East Asia and the South-West Pacific protects its sufferers from malaria, a finding that could drive future vaccine design," SciDev.Net reports.

19 Sep 2012

Pfizer announces that 14 abstracts for tofacitinib to be presented at ACR/ARHP annual meeting

Pfizer Inc. announced today that 14 abstracts for tofacitinib, an investigational oral Janus kinase (JAK) inhibitor for the treatment of adults with moderate-to-severe active rheumatoid arthritis (RA), will be presented at the American College of Rheumatology (ACR) / Association of Rheumatology Health Professionals (ARHP) 2012 Annual Meeting, which is being held November 9-14 in Washington, D.C.

18 Sep 2012

Cancer surpasses heart disease as leading cause of death among U.S. Hispanics

A new report from American Cancer Society researchers finds that despite declining death rates, cancer has surpassed heart disease as the leading cause of death among Hispanics in the U.S. In 2009, the most recent year for which actual data are available, 29,935 people of Hispanic origin in the U.S. died of cancer, compared to 29,611 deaths from heart disease.

18 Sep 2012

Researchers obtain first detailed and complete picture of PRC2 protein

The first detailed and complete picture of a protein complex that is tied to human birth defects as well as the progression of many forms of cancer has been obtained by an international team of researchers led by scientists with the U.S. Department of Energy (DOE)'s Lawrence Berkeley National Laboratory (Berkeley Lab).

18 Sep 2012

Compelling data from two ITS Flunisyn Phase I clinical trials against multiple strains of influenza A

Immune Targeting Systems Limited, an emerging leader in the development of vaccines that promote T-cell responses against viruses and cancers, today announces compelling data from two Phase I clinical trials of FlunisynTM, the Company's lead vaccine programme which elicits potent immune responses against multiple strains of influenza-A virus.

18 Sep 2012

Vaccine News and Research

Latest Vaccine News and Research

NanoBio to present data from preclinical studies at 8th Annual International RSV Symposium

Simple survey can effectively identify women with ovarian cancer symptoms

Newly discovered Eilat virus harmless and potentially valuable

Transmitted HIV strains may have evolutionary advantage, suggest scientists

Cholera vaccine stockpiles could help save lives in future outbreaks

Biovest seeks EMA approval for BiovaxID to treat non-Hodgkin's lymphoma

'Greater commitment' needed to fight NTDs

BMJ examines emergence of China as 'major new player' in global vaccine production

Bill Gates describes how 'catalytic philanthropy' can help bring vaccines, medicines to untouched markets

Scientists identify unique molecular signature in iPSCs that show promise in regenerative medicine

Study uncovers why some HIV-positive people take long time to progress to full-blown AIDS

TECHLAB to utilize Dynex's Gold SmartKit packaging for ELISA product line

Complete story behind connection between XMRV virus and prostate cancer

Dengue Vaccine Initiative launches redesigned website, new blog

VOA News report examines PEPFAR's use of generic drugs, discusses search for HIV vaccine

Hereditary blood disorder found in South-East Asia, South-West Pacific could offer clues for malaria vaccine

Pfizer announces that 14 abstracts for tofacitinib to be presented at ACR/ARHP annual meeting

Cancer surpasses heart disease as leading cause of death among U.S. Hispanics

Researchers obtain first detailed and complete picture of PRC2 protein

Compelling data from two ITS Flunisyn Phase I clinical trials against multiple strains of influenza A

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Newsletters you may be interested in